Adam Boxer
Clinical trials sponsored by Adam Boxer, explained in plain language.
-
New hope for PSP: experimental vaccine-like drug enters key trial
Disease control Not yet recruitingThis study tests whether AADvac1 can slow down progressive supranuclear palsy (PSP), a rare brain disease that affects movement, balance, and thinking. About 146 people with early-to-moderate PSP will receive the drug or a placebo. The main goal is to see if the drug reduces dise…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
New hope for rare brain disease: platform trial launches
Disease control Not yet recruitingThis study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will join this platform trial to see if any of the treatments can slow the disease. The goal i…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Hope on the horizon: new drug trial aims to slow rare brain disease PSP
Disease control Not yet recruitingThis Phase 2 trial tests whether the drug LM11A-31 can slow the progression of Progressive Supranuclear Palsy (PSP), a rare brain disease that affects movement and thinking. About 147 people with early-stage PSP will receive the drug or a placebo. The study measures changes in sy…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 18, 2026 12:02 UTC